CN Stock MarketDetailed Quotes

Anhui Wanbang Pharmaceutical Technology (301520)

Watchlist
  • 40.84
  • +0.85+2.13%
Noon Break Mar 27 11:30 CST
2.72BMarket Cap66.62P/E (TTM)

Anhui Wanbang Pharmaceutical Technology (301520) Key Financial Indicators

301520 Earnings per Share (EPS)

According to the latest financial report of Anhui Wanbang Pharmaceutical Technology, the latest earnings per share (TTM) for the company is 0.50. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

Loading...

301520 Book Value Per Share (BVPS)

Analyzing a company's fundamentals? Check out Anhui Wanbang Pharmaceutical Technology's latest financial report to see how much their book value per share (BVPS) is currently at 22.69.

Currency: CNY

Cumulative Quarterly

Loading...

301520 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Anhui Wanbang Pharmaceutical Technology shows that the company's current ratio is 21.86, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Loading...

301520 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Anhui Wanbang Pharmaceutical Technology, the quick ratio is 21.84, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

Loading...

301520 Return on Equity (ROE)

Want to learn more about the financial health of Anhui Wanbang Pharmaceutical Technology? The latest ROE figure is 2.19%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

Loading...

301520 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Anhui Wanbang Pharmaceutical Technology, the total asset return on investment (ROA) is 2.07%.

Currency: CNY

Cumulative Quarterly

Loading...

301520 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Anhui Wanbang Pharmaceutical Technology's latest financial report to see how their gross margin is doing - currently at 30.42%.

Currency: CNY

Cumulative Quarterly

Loading...

301520 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Anhui Wanbang Pharmaceutical Technology, the net profit margin is 15.81%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the prospect of a ceasefire negotiation between the US and Iran has been dominating market sentiment. On March 26 EST, President T Show More